These results indicate a compensatory relationship between Kat2a and Kat2b and highlight the pivotal role of Sgf29 in controlling the Kat2a/2b-mediated histone H3K9 acetylation and leukemia maintenance. The gene discussed is SGF29; the disease is leukemia.